Vieworks Co. Ltd
Vieworks Co., Ltd. develops, manufactures, and sells imaging systems and solutions. The company offers X-ray detectors and image processing technologies for general radiography system, dental and surgical C-arm systems, radiography and fluoroscopy system, veterinary radiography system, industrial inspection instrument, and other applications. It also provides industrial cameras; and bio imaging s… Read more
Vieworks Co. Ltd (100120) - Net Assets
Latest net assets as of September 2025: ₩236.91 Billion KRW
Based on the latest financial reports, Vieworks Co. Ltd (100120) has net assets worth ₩236.91 Billion KRW as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩353.30 Billion) and total liabilities (₩116.38 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩236.91 Billion |
| % of Total Assets | 67.06% |
| Annual Growth Rate | 12.85% |
| 5-Year Change | 39.08% |
| 10-Year Change | 179.91% |
| Growth Volatility | 6.51 |
Vieworks Co. Ltd - Net Assets Trend (2011–2024)
This chart illustrates how Vieworks Co. Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Vieworks Co. Ltd (2011–2024)
The table below shows the annual net assets of Vieworks Co. Ltd from 2011 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ₩236.80 Billion | +9.81% |
| 2023-12-31 | ₩215.64 Billion | +3.08% |
| 2022-12-31 | ₩209.20 Billion | +11.26% |
| 2021-12-31 | ₩188.04 Billion | +10.44% |
| 2020-12-31 | ₩170.25 Billion | +5.47% |
| 2019-12-31 | ₩161.42 Billion | +14.64% |
| 2018-12-31 | ₩140.80 Billion | +11.60% |
| 2017-12-31 | ₩126.17 Billion | +14.35% |
| 2016-12-31 | ₩110.34 Billion | +30.43% |
| 2015-12-31 | ₩84.60 Billion | +19.33% |
| 2014-12-31 | ₩70.90 Billion | +14.43% |
| 2013-12-31 | ₩61.95 Billion | +15.58% |
| 2012-12-31 | ₩53.60 Billion | +8.94% |
| 2011-12-31 | ₩49.20 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Vieworks Co. Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 24576533767000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ₩245.77 Billion | 103.72% |
| Common Stock | ₩5.00 Billion | 2.11% |
| Total Equity | ₩236.96 Billion | 100.00% |
Vieworks Co. Ltd Competitors by Market Cap
The table below lists competitors of Vieworks Co. Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Rexon Industrial Corp Ltd
TW:1515
|
$101.55 Million |
|
Bank Jabar
JK:BJBR
|
$101.58 Million |
|
Egetis Therapeutics AB (publ)
ST:EGTX
|
$101.65 Million |
|
Mayur Uniquoters Ltd
NSE:MAYURUNIQ
|
$101.68 Million |
|
Shanghai Taihe Water Environmental Technology Development Co Ltd
SHG:605081
|
$101.51 Million |
|
Tung Thih Electronic Co Ltd
TWO:3552
|
$101.51 Million |
|
Borosil Limited
NSE:BOROLTD
|
$101.49 Million |
|
Vakif Finansal Kiralama AS
IS:VAKFN
|
$101.47 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Vieworks Co. Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 215,612,092,440 to 236,959,575,990, a change of 21,347,483,550 (9.9%).
- Net income of 21,296,518,780 contributed positively to equity growth.
- Dividend payments of 3,213,668,850 reduced retained earnings.
- Other factors increased equity by 3,264,633,620.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩21.30 Billion | +8.99% |
| Dividends Paid | ₩3.21 Billion | -1.36% |
| Other Changes | ₩3.26 Billion | +1.38% |
| Total Change | ₩- | 9.90% |
Book Value vs Market Value Analysis
This analysis compares Vieworks Co. Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.04x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 2.44x to 1.04x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | ₩11058.32 | ₩26950.00 | x |
| 2017-12-31 | ₩12696.00 | ₩26950.00 | x |
| 2018-12-31 | ₩14287.00 | ₩26950.00 | x |
| 2019-12-31 | ₩16379.06 | ₩26950.00 | x |
| 2020-12-31 | ₩18018.77 | ₩26950.00 | x |
| 2021-12-31 | ₩20478.94 | ₩26950.00 | x |
| 2022-12-31 | ₩22784.17 | ₩26950.00 | x |
| 2023-12-31 | ₩23482.27 | ₩26950.00 | x |
| 2024-12-31 | ₩25807.22 | ₩26950.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Vieworks Co. Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 8.99%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 9.55%
- • Asset Turnover: 0.69x
- • Equity Multiplier: 1.36x
- Recent ROE (8.99%) is below the historical average (14.83%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | 14.82% | 14.80% | 0.84x | 1.19x | ₩3.41 Billion |
| 2015 | 18.79% | 17.01% | 0.96x | 1.15x | ₩7.44 Billion |
| 2016 | 24.45% | 23.00% | 0.90x | 1.18x | ₩15.95 Billion |
| 2017 | 15.56% | 15.90% | 0.90x | 1.09x | ₩7.01 Billion |
| 2018 | 14.75% | 15.81% | 0.84x | 1.11x | ₩6.69 Billion |
| 2019 | 15.00% | 17.80% | 0.75x | 1.12x | ₩8.07 Billion |
| 2020 | 13.45% | 14.28% | 0.81x | 1.16x | ₩5.87 Billion |
| 2021 | 17.80% | 17.33% | 0.80x | 1.28x | ₩14.67 Billion |
| 2022 | 12.69% | 11.15% | 0.82x | 1.38x | ₩5.62 Billion |
| 2023 | 6.82% | 6.68% | 0.75x | 1.36x | ₩-6.85 Billion |
| 2024 | 8.99% | 9.55% | 0.69x | 1.36x | ₩-2.40 Billion |
Industry Comparison
This section compares Vieworks Co. Ltd's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $88,353,406,619
- Average return on equity (ROE) among peers: 5.91%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Vieworks Co. Ltd (100120) | ₩236.91 Billion | 14.82% | 0.49x | $101.54 Million |
| Shinhung (004080) | $87.31 Billion | 3.50% | 0.52x | $10.80 Million |
| Osang Healthcare Co.,Ltd (036220) | $199.86 Billion | 20.34% | 0.25x | $37.44 Million |
| HansBiomed Corporation (042520) | $43.16 Billion | 11.38% | 0.21x | $246.58 Million |
| JVM Co. Ltd (054950) | $98.83 Billion | 10.23% | 0.72x | $117.37 Million |
| Huvitz Co. Ltd (065510) | $51.68 Billion | 16.97% | 0.32x | $43.64 Million |
| Corentec Co Ltd (104540) | $48.30 Billion | -3.04% | 0.46x | $40.80 Million |
| Hironic Co. Ltd (149980) | $40.72 Billion | 7.13% | 0.15x | $23.71 Million |
| Laseroptek Co., Ltd. (199550) | $-3.94 Billion | 0.00% | 0.00x | $21.68 Million |
| Humasis Co. Ltd (205470) | $229.26 Billion | -13.28% | 0.45x | $48.97 Million |